1-hydroxy-2-1-benzoxaborole and tavaborole

1-hydroxy-2-1-benzoxaborole has been researched along with tavaborole* in 1 studies

Other Studies

1 other study(ies) available for 1-hydroxy-2-1-benzoxaborole and tavaborole

Article	Year
Discovery of a new boron-containing antifungal agent, 5-fluoro-1,3-dihydro-1-hydroxy-2,1- benzoxaborole (AN2690), for the potential treatment of onychomycosis. Journal of medicinal chemistry, 2006, Jul-27, Volume: 49, Issue:15 A structure-activity relationship investigation for a more efficacious therapy to treat onychomycosis, a fungal infection of the toe and fingernails, led to the discovery of a boron-containing small molecule, 5-fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole (AN2690), which is currently in clinical trials for onychomycosis topical treatment. Topics: Administration, Topical; Antifungal Agents; Aspergillus fumigatus; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Candida; Microbial Sensitivity Tests; Onychomycosis; Structure-Activity Relationship; Trichophyton	2006

Article

Year

Discovery of a new boron-containing antifungal agent, 5-fluoro-1,3-dihydro-1-hydroxy-2,1- benzoxaborole (AN2690), for the potential treatment of onychomycosis.

Journal of medicinal chemistry, 2006, Jul-27, Volume: 49, Issue:15

A structure-activity relationship investigation for a more efficacious therapy to treat onychomycosis, a fungal infection of the toe and fingernails, led to the discovery of a boron-containing small molecule, 5-fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole (AN2690), which is currently in clinical trials for onychomycosis topical treatment.

Topics: Administration, Topical; Antifungal Agents; Aspergillus fumigatus; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Candida; Microbial Sensitivity Tests; Onychomycosis; Structure-Activity Relationship; Trichophyton

2006